Manabu Suzuki
Nippon Medical School
Internal medicineRadiologySurgeryPathologyDermatologyCardiologyLocal anesthesiaRespiratory failureExacerbationRheumatoid arthritisLungPneumoniaBronchoscopyThoracoscopyBronchiectasisPleural effusionTuberculosisLymphedemaAnesthesiaMedicine
42Publications
4H-index
70Citations
Publications 40
Newest
#1Takashi KatsunoH-Index: 1
#2Manabu SuzukiH-Index: 4
Last. Haruhito SugiyamaH-Index: 19
view all 8 authors...
Source
#1Yoshie TsujimotoH-Index: 2
#2Junko TeradaH-Index: 1
Last. Haruhito SugiyamaH-Index: 19
view all 24 authors...
BACKGROUND: The current gold standard in coronavirus disease (COVID-19) diagnostics is the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in nasopharyngeal swab (NPS) samples. Alternatively, nasal swab (NS) or saliva swab (SS) specimens are used, although available data on test accuracy are limited. We examined the diagnostic accuracy of NPS/NS/SS samples for this purpose. METHODS: Ten patien...
Source
#2Manabu SuzukiH-Index: 4
Last. Haruhito SugiyamaH-Index: 19
view all 10 authors...
A 62-year-old woman with rheumatoid arthritis and a history of receiving immunosuppressant therapy had a recurrence of lung adenocarcinoma with EGFR L858R mutation. Following 14 months of treatment with erlotinib, computed tomography (CT) findings revealed the presence of small diffuse nodules. Bronchoscopy was performed as metastasis was suspected; however, this was not detected on lung biopsy with forceps. Transbronchial lung cryobiopsy (TBLC) succeeded in detecting metastatic adenocarcinoma, ...
Source
#1Hiroshi TakumidaH-Index: 1
#2Shinyu IzumiH-Index: 19
Last. Masayuki HojoH-Index: 7
view all 10 authors...
Abstract A 70-year-old Japanese man contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and required oxygen to maintain oxygen saturation (>90%), 5 weeks after onset of coronavirus disease 2019 (COVID-19) symptoms. Transbronchial lung cryobiopsy revealed pathological features of organizing pneumonia with alveolar epithelial injury, and prednisolone administration led to alleviation of respiratory symptoms and recovery of respiratory function. This case report is the...
1 CitationsSource
#1Masaya SugiyamaH-Index: 33
#2Noriko KinoshitaH-Index: 6
Last. Masashi MizokamiH-Index: 81
view all 24 authors...
COVID-19, a novel coronavirus-related illness, has spread worldwide. Patients with apparently mild/moderate symptoms can suddenly develop severe pneumonia. Therefore, almost all COVID-19 patients require hospitalization, which can reduce limited medical resources in addition to overwhelming medical facilities. To identify predictive markers for the development of severe pneumonia, a comprehensive analysis of serum chemokines and cytokines was conducted using serial serum samples from COVID-19 pa...
8 CitationsSource
#1Satoru IshiiH-Index: 6
#2Hiromu WatanabeH-Index: 1
Last. Masayuki HojoH-Index: 7
view all 8 authors...
OBJECTIVE New flex-rigid pleuroscope enables observations with a maximum angle of curvature of 180° , allowing visualization of the area near the insertion site of the pleuroscope. And, it improved the image quality and channel inner diameter. The aim of this study was to evaluate the clinical effectiveness and safety of a new flex-rigid pleuroscope. METHODS A retrospective analysis of patients who were examined with a new flex-rigid pleuroscope under local anesthesia at our institution was cond...
Source
#2Manabu SuzukiH-Index: 4
Last. Haruhito SugiyamaH-Index: 19
view all 8 authors...
BACKGROUND: Currently, there are no specific effective treatments for SARS-CoV-2; however, various COVID-19 treatment options are under investigation. It is vital to continue investigating the landscape of SARS-CoV-2-induced pneumonia and therapeutic interventions. OBJECTIVE: This paper presents the protocol for a study that aims to compare the pneumonia exacerbation rate between ciclesonide (Alvesco R) administration and symptomatic treatment in COVID-19 patients and to determine the efficacy o...
1 CitationsSource
1 CitationsSource
#1Yuichiro TakedaH-Index: 16
#2Naoki Ishizuka (JFCR: Japanese Foundation for Cancer Research)H-Index: 16
Last. Haruhito SugiyamaH-Index: 19
view all 7 authors...
The recommended daily dose of erlotinib was determined for patients with all types of non-small cell lung cancer (NSCLC). We determined the optimal dose (OD) in patients with NSCLC harboring only epidermal growth factor receptor (EGFR) sensitizing mutations. EGFR-tyrosine kinase inhibitor-naive patients with sensitizing mutations were eligible. Clinical OD was determined in a phase I/II study based on the continual reassessment method (CRM) of both disease control and dose-limiting toxicity, def...
Source
#1Yuichiro TakedaH-Index: 16
#2Go NakaH-Index: 5
Last. Haruhito SugiyamaH-Index: 19
view all 7 authors...
1 CitationsSource